The fertility test market size is expected to develop at a CAGR of 7.9% during the projected period. The growing awareness about infertility and the need for early detection is increasing the sales of fertility test kits. As a result, the market value is projected to increase from US$ 548.4 million in 2024 to US$ 1.2 billion by 2034.
Fertility Test Market Insights and Analysis
Attributes | Details |
---|---|
Estimated Market Size in 2024 | US$ 548.4 million |
Forecasted Market Size by 2034 | US$ 1.2 billion |
Projected Value CAGR (2024 to 2034) | 7.9% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The demand for home-based fertility testing kits is on the rise. These kits are cost-effective and offer convenience to users, making them an attractive option for those who prefer to assess their fertility levels in the privacy of their homes. As a result, many companies are focusing on developing innovative and accurate home-based testing kits to meet this demand.
The rise of digital health technology is also creating new opportunities for market players in the fertility testing market. Mobile apps, wearables, and other digital health tools are gaining popularity among consumers. Many companies are developing fertility testing products that can be integrated with these tools.
This integration allows for a more personalized approach to fertility testing, potentially leading to better outcomes for users. Companies that can develop innovative and accurate fertility testing products catering to these trends are likely to be well-positioned for success in this market.
The ovulation prediction kit segment dominates the market by product and is projected to maintain its dominance through 2034, registering a 7.7% CAGR. The saliva segment leads the market in terms of the sample category. This segment is expected to record a CAGR of 7.4% during the forecast period.
Attributes | Details |
---|---|
Product | Ovulation prediction kit |
Forecasted CAGR From 2024 to 2034 | 7.7% |
The market is significantly influenced by the dominance of the ovulation prediction kit segment, supported by the following points:
Attributes | Details |
---|---|
By Sample | Saliva |
Forecasted CAGR from 2024 to 2034 | 7.4% |
The market is led by the saliva segment within the sample category, a fact reinforced by the following:
Countries | Forecasted CAGR from 2024 to 2034 |
---|---|
United States | 7.6% |
United Kingdom | 9.1% |
China | 8.7% |
Japan | 9.3% |
South Korea | 9.8% |
The increasing awareness among people about their reproductive health in the United States is a primary factor contributing to its dominance in the fertility test market. Other supporting factors include:
The fertility test market in the United Kingdom holds significant growth potential. Factors backing up this growth are:
The demand for fertility testing is considerable in China. This growth in the fertility test market can be attributed to the following factors:
The rise in demand for fertility tests in Japan can be attributed to the country's strict regulations on assisted reproductive technologies. In addition to this, there are several other reasons supporting the expansion of the fertility test market:
The adoption rate of fertility tests in South Korea is significantly higher than in other Asian countries, and this trend is anticipated to continue in the upcoming years. This trend is supported by:
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The fertility test market is highly competitive, with several players offering a range of products and services. These companies provide various fertility tests, ranging from prediction kits to sperm count tests. Additionally, several new players in the market are leveraging technology such as artificial intelligence and machine learning to develop advanced fertility testing solutions.
Recent Developments
The market in China is expected to progress at a CAGR of 8.7% through the forecast period.
The market is currently valued at around US$ 548.4 million in 2024.
Within the product segment, the ovulation prediction kit segment contributes the most to the market.
The United States dominates the market, exhibiting a 9.1% CAGR from 2024 to 2034.
The market is set to reach a valuation of around US$ 1.2 billion by 2034.
The market is forecasted to register a CAGR of 7.9% through 2034.
Demand for fertility tests increased at a 9.5% CAGR from 2019 to 2023.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2024 to 2034 5.3.1. Ovulation prediction kit 5.3.2. Male fertility testing products 5.3.3. Fertility monitor 5.3.4. Others 5.4. Y-o-Y Growth Trend Analysis By Product, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Product, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Sample 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Sample, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Sample, 2024 to 2034 6.3.1. Saliva 6.3.2. Blood 6.3.3. Urine 6.3.4. Others 6.4. Y-o-Y Growth Trend Analysis By Sample, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By Sample, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Mode of Purchase 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Mode of Purchase, 2019 to 2023 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Mode of Purchase, 2024 to 2034 7.3.1. Over the counter 7.3.2. Prescription based 7.4. Y-o-Y Growth Trend Analysis By Mode of Purchase, 2019 to 2023 7.5. Absolute $ Opportunity Analysis By Mode of Purchase, 2024 to 2034 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) Analysis By Application, 2019 to 2023 8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2024 to 2034 8.3.1. Female 8.3.2. Male 8.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023 8.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User 9.1. Introduction / Key Findings 9.2. Historical Market Size Value (US$ Million) Analysis By End User, 2019 to 2023 9.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2024 to 2034 9.3.1. Hospitals 9.3.2. Homecare settings 9.3.3. Fertility clinics 9.3.4. Others' 9.4. Y-o-Y Growth Trend Analysis By End User, 2019 to 2023 9.5. Absolute $ Opportunity Analysis By End User, 2024 to 2034 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 10.1. Introduction 10.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023 10.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034 10.3.1. North America 10.3.2. Latin America 10.3.3. Western Europe 10.3.4. Eastern Europe 10.3.5. South Asia and Pacific 10.3.6. East Asia 10.3.7. Middle East and Africa 10.4. Market Attractiveness Analysis By Region 11. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. USA 11.2.1.2. Canada 11.2.2. By Product 11.2.3. By Sample 11.2.4. By Mode of Purchase 11.2.5. By Application 11.2.6. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By Sample 11.3.4. By Mode of Purchase 11.3.5. By Application 11.3.6. By End User 11.4. Key Takeaways 12. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. Brazil 12.2.1.2. Mexico 12.2.1.3. Rest of Latin America 12.2.2. By Product 12.2.3. By Sample 12.2.4. By Mode of Purchase 12.2.5. By Application 12.2.6. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By Sample 12.3.4. By Mode of Purchase 12.3.5. By Application 12.3.6. By End User 12.4. Key Takeaways 13. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. Germany 13.2.1.2. UK 13.2.1.3. France 13.2.1.4. Spain 13.2.1.5. Italy 13.2.1.6. Rest of Western Europe 13.2.2. By Product 13.2.3. By Sample 13.2.4. By Mode of Purchase 13.2.5. By Application 13.2.6. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By Sample 13.3.4. By Mode of Purchase 13.3.5. By Application 13.3.6. By End User 13.4. Key Takeaways 14. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. Poland 14.2.1.2. Russia 14.2.1.3. Czech Republic 14.2.1.4. Romania 14.2.1.5. Rest of Eastern Europe 14.2.2. By Product 14.2.3. By Sample 14.2.4. By Mode of Purchase 14.2.5. By Application 14.2.6. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product 14.3.3. By Sample 14.3.4. By Mode of Purchase 14.3.5. By Application 14.3.6. By End User 14.4. Key Takeaways 15. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 15.2.1. By Country 15.2.1.1. India 15.2.1.2. Bangladesh 15.2.1.3. Australia 15.2.1.4. New Zealand 15.2.1.5. Rest of South Asia and Pacific 15.2.2. By Product 15.2.3. By Sample 15.2.4. By Mode of Purchase 15.2.5. By Application 15.2.6. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product 15.3.3. By Sample 15.3.4. By Mode of Purchase 15.3.5. By Application 15.3.6. By End User 15.4. Key Takeaways 16. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 16.2.1. By Country 16.2.1.1. China 16.2.1.2. Japan 16.2.1.3. South Korea 16.2.2. By Product 16.2.3. By Sample 16.2.4. By Mode of Purchase 16.2.5. By Application 16.2.6. By End User 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Product 16.3.3. By Sample 16.3.4. By Mode of Purchase 16.3.5. By Application 16.3.6. By End User 16.4. Key Takeaways 17. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 17.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 17.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 17.2.1. By Country 17.2.1.1. GCC Countries 17.2.1.2. South Africa 17.2.1.3. Israel 17.2.1.4. Rest of MEA 17.2.2. By Product 17.2.3. By Sample 17.2.4. By Mode of Purchase 17.2.5. By Application 17.2.6. By End User 17.3. Market Attractiveness Analysis 17.3.1. By Country 17.3.2. By Product 17.3.3. By Sample 17.3.4. By Mode of Purchase 17.3.5. By Application 17.3.6. By End User 17.4. Key Takeaways 18. Key Countries Market Analysis 18.1. USA 18.1.1. Pricing Analysis 18.1.2. Market Share Analysis, 2023 18.1.2.1. By Product 18.1.2.2. By Sample 18.1.2.3. By Mode of Purchase 18.1.2.4. By Application 18.1.2.5. By End User 18.2. Canada 18.2.1. Pricing Analysis 18.2.2. Market Share Analysis, 2023 18.2.2.1. By Product 18.2.2.2. By Sample 18.2.2.3. By Mode of Purchase 18.2.2.4. By Application 18.2.2.5. By End User 18.3. Brazil 18.3.1. Pricing Analysis 18.3.2. Market Share Analysis, 2023 18.3.2.1. By Product 18.3.2.2. By Sample 18.3.2.3. By Mode of Purchase 18.3.2.4. By Application 18.3.2.5. By End User 18.4. Mexico 18.4.1. Pricing Analysis 18.4.2. Market Share Analysis, 2023 18.4.2.1. By Product 18.4.2.2. By Sample 18.4.2.3. By Mode of Purchase 18.4.2.4. By Application 18.4.2.5. By End User 18.5. Germany 18.5.1. Pricing Analysis 18.5.2. Market Share Analysis, 2023 18.5.2.1. By Product 18.5.2.2. By Sample 18.5.2.3. By Mode of Purchase 18.5.2.4. By Application 18.5.2.5. By End User 18.6. UK 18.6.1. Pricing Analysis 18.6.2. Market Share Analysis, 2023 18.6.2.1. By Product 18.6.2.2. By Sample 18.6.2.3. By Mode of Purchase 18.6.2.4. By Application 18.6.2.5. By End User 18.7. France 18.7.1. Pricing Analysis 18.7.2. Market Share Analysis, 2023 18.7.2.1. By Product 18.7.2.2. By Sample 18.7.2.3. By Mode of Purchase 18.7.2.4. By Application 18.7.2.5. By End User 18.8. Spain 18.8.1. Pricing Analysis 18.8.2. Market Share Analysis, 2023 18.8.2.1. By Product 18.8.2.2. By Sample 18.8.2.3. By Mode of Purchase 18.8.2.4. By Application 18.8.2.5. By End User 18.9. Italy 18.9.1. Pricing Analysis 18.9.2. Market Share Analysis, 2023 18.9.2.1. By Product 18.9.2.2. By Sample 18.9.2.3. By Mode of Purchase 18.9.2.4. By Application 18.9.2.5. By End User 18.10. Poland 18.10.1. Pricing Analysis 18.10.2. Market Share Analysis, 2023 18.10.2.1. By Product 18.10.2.2. By Sample 18.10.2.3. By Mode of Purchase 18.10.2.4. By Application 18.10.2.5. By End User 18.11. Russia 18.11.1. Pricing Analysis 18.11.2. Market Share Analysis, 2023 18.11.2.1. By Product 18.11.2.2. By Sample 18.11.2.3. By Mode of Purchase 18.11.2.4. By Application 18.11.2.5. By End User 18.12. Czech Republic 18.12.1. Pricing Analysis 18.12.2. Market Share Analysis, 2023 18.12.2.1. By Product 18.12.2.2. By Sample 18.12.2.3. By Mode of Purchase 18.12.2.4. By Application 18.12.2.5. By End User 18.13. Romania 18.13.1. Pricing Analysis 18.13.2. Market Share Analysis, 2023 18.13.2.1. By Product 18.13.2.2. By Sample 18.13.2.3. By Mode of Purchase 18.13.2.4. By Application 18.13.2.5. By End User 18.14. India 18.14.1. Pricing Analysis 18.14.2. Market Share Analysis, 2023 18.14.2.1. By Product 18.14.2.2. By Sample 18.14.2.3. By Mode of Purchase 18.14.2.4. By Application 18.14.2.5. By End User 18.15. Bangladesh 18.15.1. Pricing Analysis 18.15.2. Market Share Analysis, 2023 18.15.2.1. By Product 18.15.2.2. By Sample 18.15.2.3. By Mode of Purchase 18.15.2.4. By Application 18.15.2.5. By End User 18.16. Australia 18.16.1. Pricing Analysis 18.16.2. Market Share Analysis, 2023 18.16.2.1. By Product 18.16.2.2. By Sample 18.16.2.3. By Mode of Purchase 18.16.2.4. By Application 18.16.2.5. By End User 18.17. New Zealand 18.17.1. Pricing Analysis 18.17.2. Market Share Analysis, 2023 18.17.2.1. By Product 18.17.2.2. By Sample 18.17.2.3. By Mode of Purchase 18.17.2.4. By Application 18.17.2.5. By End User 18.18. China 18.18.1. Pricing Analysis 18.18.2. Market Share Analysis, 2023 18.18.2.1. By Product 18.18.2.2. By Sample 18.18.2.3. By Mode of Purchase 18.18.2.4. By Application 18.18.2.5. By End User 18.19. Japan 18.19.1. Pricing Analysis 18.19.2. Market Share Analysis, 2023 18.19.2.1. By Product 18.19.2.2. By Sample 18.19.2.3. By Mode of Purchase 18.19.2.4. By Application 18.19.2.5. By End User 18.20. South Korea 18.20.1. Pricing Analysis 18.20.2. Market Share Analysis, 2023 18.20.2.1. By Product 18.20.2.2. By Sample 18.20.2.3. By Mode of Purchase 18.20.2.4. By Application 18.20.2.5. By End User 18.21. GCC Countries 18.21.1. Pricing Analysis 18.21.2. Market Share Analysis, 2023 18.21.2.1. By Product 18.21.2.2. By Sample 18.21.2.3. By Mode of Purchase 18.21.2.4. By Application 18.21.2.5. By End User 18.22. South Africa 18.22.1. Pricing Analysis 18.22.2. Market Share Analysis, 2023 18.22.2.1. By Product 18.22.2.2. By Sample 18.22.2.3. By Mode of Purchase 18.22.2.4. By Application 18.22.2.5. By End User 18.23. Israel 18.23.1. Pricing Analysis 18.23.2. Market Share Analysis, 2023 18.23.2.1. By Product 18.23.2.2. By Sample 18.23.2.3. By Mode of Purchase 18.23.2.4. By Application 18.23.2.5. By End User 19. Market Structure Analysis 19.1. Competition Dashboard 19.2. Competition Benchmarking 19.3. Market Share Analysis of Top Players 19.3.1. By Regional 19.3.2. By Product 19.3.3. By Sample 19.3.4. By Mode of Purchase 19.3.5. By Application 19.3.6. By End User 20. Competition Analysis 20.1. Competition Deep Dive 20.1.1. AdvaCare Pharma - (USA) 20.1.1.1. Overview 20.1.1.2. Product Portfolio 20.1.1.3. Profitability by Market Segments 20.1.1.4. Sales Footprint 20.1.1.5. Strategy Overview 20.1.1.5.1. Marketing Strategy 20.1.2. Prestige Consumer Healthcare, Inc. (USA) 20.1.2.1. Overview 20.1.2.2. Product Portfolio 20.1.2.3. Profitability by Market Segments 20.1.2.4. Sales Footprint 20.1.2.5. Strategy Overview 20.1.2.5.1. Marketing Strategy 20.1.3. Babystart - (USA) 20.1.3.1. Overview 20.1.3.2. Product Portfolio 20.1.3.3. Profitability by Market Segments 20.1.3.4. Sales Footprint 20.1.3.5. Strategy Overview 20.1.3.5.1. Marketing Strategy 20.1.4. Fertility Focus Limited (UK) 20.1.4.1. Overview 20.1.4.2. Product Portfolio 20.1.4.3. Profitability by Market Segments 20.1.4.4. Sales Footprint 20.1.4.5. Strategy Overview 20.1.4.5.1. Marketing Strategy 20.1.5. bioZhena Corporation - (USA) 20.1.5.1. Overview 20.1.5.2. Product Portfolio 20.1.5.3. Profitability by Market Segments 20.1.5.4. Sales Footprint 20.1.5.5. Strategy Overview 20.1.5.5.1. Marketing Strategy 20.1.6. Prestige Consumer Healthcare, Inc. (USA) 20.1.6.1. Overview 20.1.6.2. Product Portfolio 20.1.6.3. Profitability by Market Segments 20.1.6.4. Sales Footprint 20.1.6.5. Strategy Overview 20.1.6.5.1. Marketing Strategy 20.1.7. Church & Dwight Co., Inc. (USA) 20.1.7.1. Overview 20.1.7.2. Product Portfolio 20.1.7.3. Profitability by Market Segments 20.1.7.4. Sales Footprint 20.1.7.5. Strategy Overview 20.1.7.5.1. Marketing Strategy 20.1.8. UEBE Medical GmbH (Germany) 20.1.8.1. Overview 20.1.8.2. Product Portfolio 20.1.8.3. Profitability by Market Segments 20.1.8.4. Sales Footprint 20.1.8.5. Strategy Overview 20.1.8.5.1. Marketing Strategy 20.1.9. Geratherm Medical AG (Germany) 20.1.9.1. Overview 20.1.9.2. Product Portfolio 20.1.9.3. Profitability by Market Segments 20.1.9.4. Sales Footprint 20.1.9.5. Strategy Overview 20.1.9.5.1. Marketing Strategy 20.1.10. Valley Electronics AG (Switzerland) 20.1.10.1. Overview 20.1.10.2. Product Portfolio 20.1.10.3. Profitability by Market Segments 20.1.10.4. Sales Footprint 20.1.10.5. Strategy Overview 20.1.10.5.1. Marketing Strategy 20.1.11. Geratherm Medical AG (Germany) 20.1.11.1. Overview 20.1.11.2. Product Portfolio 20.1.11.3. Profitability by Market Segments 20.1.11.4. Sales Footprint 20.1.11.5. Strategy Overview 20.1.11.5.1. Marketing Strategy 21. Assumptions & Acronyms Used 22. Research Methodology
Explore Healthcare Insights
View Reports